Co-Authors
This is a "connection" page, showing publications co-authored by Wei Wang and Liang Huang.
Connection Strength
0.055
-
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020 Jul; 146(1):137-146.e3.
Score: 0.055
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.